Target intelligence / Profile preview

Beta-galactosidase (β-gal or LacZ (for the E. coli gene/protein))

Target
β-gal or LacZ (for the E. coli gene/protein)
Molecular classification
Enzyme, Glycoside hydrolase family 2 (GH2), Hydrolase
01

Overview

Beta-galactosidase is an enzyme that catalyzes the hydrolysis of terminal non-reducing β-D-galactose residues from β-D-galactosides such as lactose, producing glucose and galactose—key steps in carbohydrate metabolism across many organisms including bacteria (*E. coli*), fungi, plants, and animals[1][7]. In *E. coli*, it also converts some lactose into allolactose, which acts as an inducer molecule regulating expression of genes involved in lactose uptake and metabolism through the lac operon system—a foundational model for understanding gene regulation mechanisms[3]. Deficiency leads to conditions like lactose intolerance; severe inherited deficiencies can cause more serious metabolic disorders such as galactosialidosis or Morquio syndrome B[5]. In biotechnology, beta-gal serves extensively both as a reporter gene product ("blue/white screening") due to its ability to cleave artificial substrates like X-GAL yielding colored products,[6] and industrially for production of prebiotic oligosaccharides using microbial enzymes with high specificity toward various glycosyl linkages.[2]

Other names
Beta-galβ-GalLactase (in some contexts)LacZ (gene/protein from E. coli)EC 3.2.1.23
02

Mechanism of action

For supplements: Enzymatic hydrolysis—exogenous beta-galactosidase breaks down dietary lactose into absorbable monosaccharides. For research/biotechnology applications: Cleavage of chromogenic substrates such as X-Gal to produce detectable products for reporter assays

03

Biological functions

Hydrolysis of lactose into glucose and galactoseSynthesis of allolactose from lactose (regulatory function in lac operon)Marker gene for monitoring gene expression in molecular biology
04

Disease associations

Lactose intolerance due to deficiency or inactivityGalactosialidosis and Morquio syndrome B (severe deficiencies)Other lysosomal storage diseases
05

Safety considerations

Generally safe when used as an oral supplement; rare allergic reactions possible.Therapeutic challenges include stability of enzyme preparations and delivery to appropriate sites within the body.
06

Interacting drugs

Lactase supplements
07

Biomarkers

Deficiency/activity levels serve as biomarkers for diagnosing lactose intolerance and certain lysosomal storage diseases.Expression/activity used as a biomarker/reporter in genetic engineering experiments ("blue/white screening")

Beyond the preview

Go deeper on Beta-galactosidase (β-gal or LacZ (for the E. coli gene/protein)).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beta-galactosidase (β-gal or LacZ (for the E. coli gene/protein)).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call